🔎 Trials Near Me

Home › Overweight › Ohio › Cincinnati

Pag-aaral pangklinika para sa Overweight sa Cincinnati, OH

14 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Cincinnati (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 2
  • CTI Clinical Research Center /ID# 282043, Cincinnati
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07752979

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Nagre-recruitPhase 3
  • Midwest Eye Center, Cincinnati
  • Velocity Clinical Research, Mt. Auburn, Cincinnati
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07595549

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2
  • CTI Clinical Research Center, Cincinnati
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Nagre-recruitPhase 3
  • CTI Clinical Research Center, Cincinnati
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Nagre-recruitPhase 3
  • CTI Clinical Research Center, Cincinnati
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Nagre-recruitPhase 3
  • Velocity Clinical Research - Auburn, Cincinnati
Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 3
  • AURORA-1 Clinical Site, Cincinnati
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Nagre-recruitPhase 3
  • AURORA-2 Clinical Site, Cincinnati
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2
  • CTI Clinical Research Center, Cincinnati
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Nagre-recruitPhase 3
  • Velocity Clinical Research - Cincinnati, Cincinnati
  • Velocity Clinical Research - Springdale, Cincinnati
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684144

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Nagre-recruitPhase 3
  • Clinical Trial Investigator Clinical Research Center, Cincinnati
  • Velocity Clinical Research - Cincinnati, Cincinnati
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684235

Effects of Exercise on Lipids and Endothelial Function in Youth

Nagre-recruit
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Edad 10 hanggang 20 · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT07409064

Pag-aaral para sa Overweight sa ibang lungsod

Iba pang pag-aaral sa Cincinnati

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.